Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms |
Target |
Mechanism TSPO inhibitors(Translocator protein inhibitors), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H25FN2O5 |
InChIKeyWDCDJYGFOQXTQD-FNNGWQQSSA-N |
CAS Registry1207345-42-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque, Atherosclerotic | Preclinical | FI | 25 May 2016 | |
Plaque, Atherosclerotic | Preclinical | DE | 25 May 2016 | |
Plaque, Atherosclerotic | Preclinical | DE | 25 May 2016 |